Treatment of anxiety neuroses in general practice using Lorazepam (Tavor)
Kaemmerer, E.
Münchener Medizinische Wochenschrift 114(29): 1296-1298
1972
ISSN/ISBN: 0341-3098 PMID: 5068376 Document Number: 56546
Document emailed within 1 workday
Related Documents
Meusert, W. 1973: Treatment results with Tavor (lorazepam) in psychosomatic disorders. Evaluation of findings using patient questionnaires and test scale Fortschritte der Medizin 91(30): 1197-1205Ruiz, A.T. 1983: A double-blind study of alprazolam and lorazepam in the treatment of anxiety Journal of Clinical Psychiatry 44(2): 60-62
Danion, J.M.; Brion, S.; Escande, M.; Ropert, R.; Sacquepee, L.; Singer, L.; Scotto, J.C. 1984: Treatment of anxiety with prazepam, 40 mg. a controlled study versus lorazepam L'Encephale 10(3): 135-138
Lemoine, P.; Rouillon, F.; Pouget, D. 1996: Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders L'Encephale 22(6): 461-467
Bernardi, F.; Fossi, L.; Faravelli, C.; Corsini, G.U.; Varricchio, M.C. 1984: Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study Rivista di Patologia Nervosa E Mentale 105(1): 1-13
Beaumont, G. 1990: The management of anxiety in general practice Postgraduate Medical Journal 66(Suppl 2): S41-S44
Janssen, P.L. 1982: The position of anxiety in neuroses Münchener Medizinische Wochenschrift 124(12): 285-289
Rouillon, F.; Thalassinos, M.; Ferreri, M.; Parquet, P.; Samuelian, J.C. 1994: Clinical and epidemiologic study of "generalized anxiety" in general practice L'Encephale 20(2): 103-110
Jouvent, R.; Bungener, C.; Morand, P.; Millet, V.; Lancrenon, S.; Ferreri, M. 1999: Distinction between anxiety state/trait in general practice: a descriptive study L'Encephale 25(1): 44-49
McCurdy, L.; Schatzberg, A.F. 1978: Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology Journal of Clinical Psychiatry 39(10 Part 2): 30-34
Hart, W.L.; Parmley, L.F. 1978: The effect of lorazepam on hypertension-associated anxiety: a double-blind study Journal of Clinical Psychiatry 39(10 Part 2): 41-45
Semaan, W.; Hergueta, T.; Bloch, J.; Charpak, Y.; Duburcq, A.; Le Guern, M.E.; Alquier, C.; Rouillon, F. 2001: Cross-sectional study of the prevalence of adjustment disorder with anxiety in general practice L'Encephale 27(3): 238-244
Ivanov, S.V.; Il'ina, N.A.; Burlakov, A.V. 2003: Spectrum of therapeutic efficacy and safety of Lorafen (lorazepam) use for anxiety disorders Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 103(8): 38-41
2001: Large general practice study with repaglinide. Fewer "anxiety eating" in diabetic patients MMW Fortschritte der Medizin 143(10): 47-48
Montgomery, B.A.; Cullinan, T.R.; Bayley, A.J. 1970: A double-blind comparative trial of doxepin hydrochloride and chlordiazepoxide in anxiety and depression in general practice British Journal of Clinical Practice 24(5): 207-209
Riemann, D. 1996: Anxiety disorders. Diagnosis and therapy in family practice. 1: Anxiety reactions--psychiatric disorders and anxiety--anxiety disorders Fortschritte der Medizin 114(33): 457-459
Jankulov-Demjen, M. 1988: The effect of anxiety neuroses on success in studies in students at the Novi Sad University Medicinski Pregled 41(3-4): 149-150
Rosenberg, I.U.; Ostensen, A.I.; Fonnelo, H. 1976: Double-blind multicenter trial in general practice on fluphenthixol versus nortriptyline in patients with anxiety-depression-asthenia (the "ADA"-syndrome) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 96(4): 229-233; 255
Malterud, K.; Bruusgaard, D. 1986: General practice training for general practitioners and a basic course in general practice. a pedagogic experiment--a contribution to the development of the field Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(17-18): 1498-1500
Lorentzson, S. 1975: Problems in the treatment of anxiety. Viewpoints of a general practitioner Lakartidningen 72(24): 2617-2618